Methylprednisolone-rituximab is an effective salvage therapy for patients with relapsed chronic lymphocytic leukemia including those with unfavorable cytogenetic features.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples